Norges Bank’s Health Catalyst HCAT Stock Holding History

Norges Bank’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-240,100	Closed	-$2.55M	–	2121
2022 Q4	$2.55M	Buy	+240,100	New	+$2.32M	﹤0.01%	1935
2022 Q3	–	Sell	-211,600	Closed	-$3.07M	–	2105
2022 Q2	$3.07M	Buy	+211,600	New	+$3.61M	﹤0.01%	1843
2022 Q1	–	Sell	-152,167	Closed	-$6.03M	–	2199
2021 Q4	$6.03M	Buy	152,167 +95,632	+169%	+$4.36M	﹤0.01%	1887
2021 Q3	$2.83M	Buy	56,535 +40,000	+242%	+$2.18M	﹤0.01%	2002
2021 Q2	$918K	Buy	+16,535	New	+$881K	﹤0.01%	2125
2020 Q3	–	Sell	-15,000	Closed	-$438K	–	2144
2020 Q2	$438K	Hold	15,000	–	–	﹤0.01%	2054
2020 Q1	$392K	Hold	15,000	–	–	﹤0.01%	2017
2019 Q4	$521K	Hold	15,000	–	–	﹤0.01%	2051
2019 Q3	$475K	Buy	+15,000	New	+$590K	﹤0.01%	2065

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Norges Bank's HCAT Position: Q1 2023 in Review

Norges Bank sold out of Health Catalyst (HCAT) in Q1 2023, closing a stake of 240,100 shares — an estimated $2.55M sold.

Norges Bank first reported a position in HCAT in Q3 2019 and held it in 9 quarters. The position peaked at $6.03M in Q4 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q1 2023.

Norges Bank reported no remaining Health Catalyst position as of Q1 2023 after selling out during the quarter.
Norges Bank sold 240,100 Health Catalyst shares in Q1 2023, an estimated $2.55M.
Norges Bank first reported a position in Health Catalyst in Q3 2019 and held it in 9 quarters.
Norges Bank's Health Catalyst position peaked at $6.03M in Q4 2021.
161 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2023.

Based on Norges Bank's 13F filing for Q1 2023, filed 15 May 2023.